{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:33:10Z","timestamp":1791397990290,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.cbi.2008.04.045","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T08:40:57Z","timestamp":1210236057000},"page":"222-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Study of neuroprotection of donepezil, a therapy for Alzheimer's disease"],"prefix":"10.1016","volume":"175","author":[{"given":"S.","family":"Akasofu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kosasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2008.04.045_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(91)91553-D","article-title":"In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity","volume":"563","author":"Pike","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2008.04.045_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: nosological evidence","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.cbi.2008.04.045_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"issue":"Suppl. 9","key":"10.1016\/j.cbi.2008.04.045_bib4","first-page":"22","article-title":"Pharmacologic approaches to cognitive deficits in Alzheimer's disease","volume":"59","author":"Peskind","year":"1998","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.cbi.2008.04.045_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.2000.tb06942.x","article-title":"Cholinesterase inhibitors stabilize Alzheimer's disease","volume":"9202000","author":"Giacobini","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2008.04.045_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00093-4","article-title":"Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?","volume":"346","author":"Benzi","year":"1998","journal-title":"Eur J. Pharmacol."},{"key":"10.1016\/j.cbi.2008.04.045_bib7","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1021\/jm00024a009","article-title":"Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl) methyl]piperidine hydrochloride and related compounds","volume":"38","author":"Sugimoto","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2008.04.045_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002018-199819060-00004","article-title":"Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology","volume":"19","author":"Nordberg","year":"1998","journal-title":"Drug Safety"},{"key":"10.1016\/j.cbi.2008.04.045_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1176\/jnp.11.2.268","article-title":"Use of donepezil for vascular dementia: preliminary clinical experience","volume":"11","author":"Mendez","year":"1999","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.cbi.2008.04.045_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1749-6632.2002.tb04859.x","article-title":"the donepezil VaD 307 and 308 study groups, donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits","volume":"977","author":"Pratt","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.cbi.2008.04.045_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(03)01865-X","article-title":"Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen\u2013glucose deprivation","volume":"472","author":"Akasofu","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2008.04.045_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2005.11.057","article-title":"Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity","volume":"530","author":"Akasofu","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2008.04.045_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2005.04.014","article-title":"Protective effect of donepezil against A\u03b2 (1\u201340) neurotoxicity in rat septal neurons","volume":"1047","author":"Kimura","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2008.04.045_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2005.08.036","article-title":"Comparison of donepezil and memantine for protective effect against amyloid-beta(1\u201342) toxicity in rat septal neurons","volume":"391","author":"Kimura","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cbi.2008.04.045_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(87)90041-0","article-title":"Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay","volume":"20","author":"Koh","year":"1987","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.cbi.2008.04.045_bib16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1471-4159.1989.tb02554.x","article-title":"1-Aminocyclopropanecarboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-d-aspartate receptor complex","volume":"52","author":"Marvizon","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2008.04.045_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1358\/mf.2000.22.8.701373","article-title":"Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro","volume":"22","author":"Ogura","year":"2000","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2008.04.045_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2008.04.045_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2008.04.045_bib20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.cbi.2008.04.045_bib21","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/jm0340602","article-title":"3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy","volume":"46","author":"Piazzi","year":"2003","journal-title":"J. Med. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279708002123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279708002123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:15:53Z","timestamp":1757855753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279708002123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":21,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0009279708002123"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2008.04.045","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of neuroprotection of donepezil, a therapy for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2008.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}